Optimizing safety surveillance for COVID-19 vaccines

被引：33
|
作者：
Chandler, Rebecca E. [1 ]
机构：
[1] Uppsala Monitoring Ctr, Uppsala, Sweden
来源：
NATURE REVIEWS IMMUNOLOGY | 2020年 / 20卷 / 08期
关键词：
D O I：
10.1038/s41577-020-0372-8
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Evolution of the current infrastructure for surveillance of vaccine safety will be essential to meet our commitments to the public in the deployment of a vaccine (or vaccines) to COVID-19. The incorporation of concepts and tools within the fields of data science and systems immunology can be used to propel vaccine safety monitoring into the twenty-first century.
引用
收藏
页码：451 / 452
页数：2
相关论文
共 50 条
  • [31] The Impact of Mobile Apps for Spontaneous Reporting: Experience from COVID-19 Vaccines Safety Surveillance
    Magro, L.
    Imbrici, P.
    Rubbi, S.
    Arzenton, E.
    Lora, R.
    Stano, M. G.
    Girotti, S.
    Petrelli, G.
    Moretti, U.
    [J]. DRUG SAFETY, 2022, 45 (10) : 1229 - 1229
  • [32] Active Safety Surveillance of Four Types of COVID-19 Vaccines: A National Study from Jordan
    Abdel-Qader, Derar H.
    Abdel-Qader, Hasan
    Silverthorne, Jennifer
    Kongkaew, Chuenjid
    Al Meslamani, Ahmad Z.
    Hayajneh, Wail
    Abu Ata, Osama M.
    Shnaigat, Walid
    AbuRuz, Salah
    Al Nsour, Mohannad
    Alhariri, Abdallah
    Shnewer, Khaldoun
    Da'ssan, Mohammad
    Obeidat, Nathir M.
    Nusair, Khaldoon E.
    Jalamdeh, Mothafer S.
    Hawari, Feras
    Khader, Khaldoun
    Hakim, Tareq
    Hammad, Fatima A.
    Al Qudah, Mustafa
    Asad, Mohammad
    [J]. CLINICAL DRUG INVESTIGATION, 2022, 42 (10) : 813 - 827
  • [33] Active Safety Surveillance of Four Types of COVID-19 Vaccines: A National Study from Jordan
    Derar H. Abdel-Qader
    Hasan Abdel-Qader
    Jennifer Silverthorne
    Chuenjid Kongkaew
    Ahmad Z. Al Meslamani
    Wail Hayajneh
    Osama M. Abu Ata
    Walid Shnaigat
    Salah AbuRuz
    Mohannad Al Nsour
    Abdallah Alhariri
    Khaldoun Shnewer
    Mohammad Da’ssan
    Nathir M. Obeidat
    Khaldoon E. Nusair
    Mothafer S. Jalamdeh
    Feras Hawari
    Khaldoun Khader
    Tareq Hakim
    Fatima A. Hammad
    Mustafa Al Qudah
    Mohammad Asad
    [J]. Clinical Drug Investigation, 2022, 42 : 813 - 827
  • [34] Safety of COVID-19 vaccines and effect of COVID-19 infection in children with milk allergies
    Kwon, Junghyun
    Mazer, Bruce
    Mule, Pasquale
    McCusker, Christine
    Beaudette, Liane
    Ouamrane, Manel
    Ben-Shoshan, Moshe
    Lejtenyi, Duncan
    Ke, Danbing
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB177 - AB177
  • [35] COVID-19 Vaccines for Optimizing Immunity in the Upper Respiratory Tract
    Ramasamy, Ranjan
    [J]. VIRUSES-BASEL, 2023, 15 (11):
  • [36] COVID-19 Vaccines and Hyperglycemia-Is There a Need for Postvaccination Surveillance?
    Samuel, Samson Mathews
    Varghese, Elizabeth
    Triggle, Chris R.
    Busselberg, Dietrich
    [J]. VACCINES, 2022, 10 (03)
  • [37] Efficacy and Safety of COVID-19 Vaccines-An Update
    Sharma, Eshani
    Revinipati, Sraddha
    Bhandari, Saisha
    Thakur, Sejal
    Goyal, Shubham
    Ghose, Aruni
    Bajpai, Sukrit
    Muhammad, Waleed
    Boussios, Stergios
    [J]. DISEASES, 2022, 10 (04)
  • [38] Safety of mRNA COVID-19 vaccines during pregnancy
    Ellington, Sascha
    Olson, Christine K.
    [J]. LANCET INFECTIOUS DISEASES, 2022, 22 (11): : 1514 - 1515
  • [39] Safety of mRNA COVID-19 vaccines during pregnancy
    [J]. Reactions Weekly, 2022, 1910 (1) : 9 - 9
  • [40] Second HPRA safety update on COVID-19 vaccines
    [J]. Reactions Weekly, 2021, 1843 (1) : 4 - 4
12345